Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ProPhase Labs (PRPH) Operating Expenses (2016 - 2025)

Historic Operating Expenses for ProPhase Labs (PRPH) over the last 16 years, with Q3 2025 value amounting to $4.6 million.

  • ProPhase Labs' Operating Expenses fell 3067.96% to $4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.6 million, marking a year-over-year increase of 713.96%. This contributed to the annual value of $38.5 million for FY2024, which is 463.07% up from last year.
  • As of Q3 2025, ProPhase Labs' Operating Expenses stood at $4.6 million, which was down 3067.96% from $4.6 million recorded in Q2 2025.
  • Over the past 5 years, ProPhase Labs' Operating Expenses peaked at $17.1 million during Q4 2024, and registered a low of $4.2 million during Q1 2025.
  • Over the past 5 years, ProPhase Labs' median Operating Expenses value was $7.7 million (recorded in 2021), while the average stood at $8.8 million.
  • In the last 5 years, ProPhase Labs' Operating Expenses soared by 52803.59% in 2021 and then crashed by 5590.3% in 2023.
  • Over the past 5 years, ProPhase Labs' Operating Expenses (Quarter) stood at $10.9 million in 2021, then soared by 49.65% to $16.4 million in 2022, then crashed by 55.9% to $7.2 million in 2023, then soared by 137.4% to $17.1 million in 2024, then plummeted by 72.92% to $4.6 million in 2025.
  • Its Operating Expenses stands at $4.6 million for Q3 2025, versus $4.6 million for Q2 2025 and $4.2 million for Q1 2025.